Breakthrough technology for treating skin wounds

About Us

Vaporox was formed to commercialize Vaporous Hyperoxia Therapy (VHT™), our patented and FDA-510(k)-cleared technology that represents a breakthrough in treating 9 different types of skin wounds, including diabetic foot ulcers (DFUs), as well as amputations, burns, frostbite, gangrene, pressure ulcers (bed sores) and skin grafts.

 

There are 2.1 million people in the U.S. living with an amputation, and this population is expected to double by 2050. Worldwide, annual limb amputations exceed one million.

About Us

Vaporox was formed to commercialize Vaporous Hyperoxia Therapy (VHT™), our patented and FDA-510(k)-cleared technology that represents a breakthrough in treating 7 different types of skin wounds, including diabetic foot ulcers (DFUs), as well as amputations, burns, frostbite, gangrene, pressure ulcers (bed sores) and skin grafts.

There are 2.1 million people in the U.S. living with an amputation, and this population is expected to double by 2050. Worldwide, annual limb amputations exceed one million.

Beyond DFUs

After establishing VHT as the preferred treatment for DFUs, Vaporox intends to look at extending its technology to treat other types of skin wounds and maladies, or licensing VHT to other medical device companies.

Meet the Vaporox Team

We’ve brought together a strong mix of talented people who are passionate about helping others

Alan Sage

CEO and Board Member
My career has largely been in startup ventures. I have lead and built sales at a start up from zero to $25 million/year, and managed over a hundred million in enterprise product sales in my career. I have also led and built a company from concept to market leadership and “Series B” VC investment. I have contributed to successful exits, via both IPO, and acquisition. I frequently work with other entrepreneurs and executives to help them grow their ideas and organizations.

Loren Hutchins

Chief Product Officer
Loren received his B.S of Engineering, Mechanical Specialty from the Colorado School of Mines. Loren has worked in machine design and automated equipment development since 1994, specializing in the medical industry for the last 20 years. Working in both the consulting arena and for OEM companies, he has participated in over 5 major development initiatives taking a Greenfield concept through complete product realization with FDA 510(k) approvals, and successfully passing FDA and ISO audits on all efforts.

Wes Weber

Product Specialist
Wes Weber received his B.S in Electrical Engineering from Colorado School of Mines. He has been a leader in medical device development for 23 years, providing design and development consulting services to over 40 companies. He enjoys working with small startup companies and provides efficient quick-turn development, prototyping and testing capabilities. Wes’ knowledge of industry standards, risk management, and design controls allows him to guide the design to ensure straightforward FDA clearance. Wes has been awarded 11 patents related to medical devices.

Stan Ajemian

Product Manager

Stan Ajemian has over 15 years of experience in Marketing and Product Management in medical device companies, primarily in the highly competitive orthopedic and spine industries. He led the marketing efforts of a medical device startup, drove fast growth of two small companies, and established a highly successful division of a large multinational corporation. He received his M.Sc. in Medical Science at the University of Calgary, and published 7 papers prior to transitioning to marketing. His passion is developing and promoting good medical devices that make a difference by improving people’s lives.

Louis Woodhill

Board Chairman
Louis Woodhill a software entrepreneur that is currently an investor and board member in two startup companies. He has a B.S. in mechanical engineering. Louis’ current passion is helping people make their dreams come true. Louis recently reinvented himself as an economist, because he is concerned about the way that our dysfunctional economy is crushing the dreams of so many people. Louis has published 270 articles on economics, and he is convinced that prosperity is possible.

Alex Goldstein

Board Member

Alex Goldstein is a retired start-up CEO who successfully sold the company through a competitive bidding process.  He has served on the board of two successful start-ups. His primary skill set is turnaround management and business disruption. Alex has performed in this capacity for both small technology companies and multiple businesses within Fortune 500 companies. At various times he has directed financial, marketing, IT, planning, risk management and acquisition and divestitures within these enterprises.  Alex has an MBA from Harvard Business School.

Learn More

Please enter your information below

Cancel

Send Me Updates

Updates on the new standart of wound care coming soon

Cancel

Join Our Team

Please enter your information below

Cancel

Send us a Message

We welcome your communication

Cancel

Get Involved

Do you have any of the following?


Cancel

Get Involved

Please enter your contact info

Cancel

Get Involved

Who are you?

Next
Cancel

Get Involved

Which type of facility are you associated with?


Next
Cancel

Get Involved

What is your role?


Cancel

Get Involved

Please enter your contact info

Cancel

Get Involved

Which type of investor are you?


Cancel

Get Involved

Please enter your contact info

Cancel

Get Involved

Please enter your contact info

Cancel